Serial 97757392
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Feb 2025)
What this means for you
This application is over — abandoned 03 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97757392
- Mark type
- Design / logo
- Filed
- 17 Jan 2023
- Published for opposition
- 07 Nov 2023
- Abandoned
- 03 Feb 2025
- Attorney of record
- Susan N. Acquista, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
- Class 042 — Scientific and technological services: Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
Owner
- AI Therapeutics, Inc., Guilford, CT, US
- AI Therapeutics, Inc., Guilford, CT, US
Prosecution history
- 03 Feb 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Feb 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2024 — SOU EXTENSION 1 GRANTED
- 02 May 2024 — SOU EXTENSION 1 FILED
- 02 May 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2023 — PUBLISHED FOR OPPOSITION
- 18 Oct 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED